argenx SE reported $371.14M in Operating Profit for its fiscal quarter ending in December of 2025.





Operating Profit Change Date
AstraZeneca USD 2.97B 4.48B Dec/2025
Galapagos EUR 780.56M 822.23M Dec/2025
Genmab DKK 260M 199M Dec/2025
GlaxoSmithKline GBP 1.44B 1.35B Dec/2025
GRIFOLS EUR 275.38M 76.74M Dec/2025
Hikma Pharmaceutical USD 348M 161M Dec/2025
Qiagen NV USD 121.88M 15.41M Dec/2025
UCB EUR 1.29B 571M Dec/2025